Methanobrevibacter

From WikiMD's Medical Encyclopedia

Revision as of 19:33, 17 March 2025 by Prab (talk | contribs) (CSV import)
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)

Methanobrevibacter is a genus of microorganisms that belongs to the archaeal domain. They are known for their ability to produce methane gas as a metabolic byproduct, hence their classification as methanogens. Methanobrevibacter species are commonly found in the gastrointestinal tract of humans and other animals, where they play a crucial role in the digestion process.

Biology and Ecology[edit]

Methanobrevibacter species are anaerobic, meaning they thrive in environments devoid of oxygen. They are also thermophilic, with optimal growth occurring at high temperatures. These characteristics make them well-suited to the harsh conditions of the gastrointestinal tract.

In terms of their ecological role, Methanobrevibacter species contribute to the carbon cycle by converting carbon dioxide and hydrogen into methane. This process, known as methanogenesis, is a form of anaerobic respiration.

Health Implications[edit]

While Methanobrevibacter species are generally harmless, they have been implicated in some health conditions. For instance, an overgrowth of these organisms in the gut can lead to bloating and flatulence. They have also been associated with periodontal disease and irritable bowel syndrome.

Research and Future Directions[edit]

Research on Methanobrevibacter is ongoing, with scientists seeking to better understand their biology, ecology, and health implications. There is also interest in harnessing their methane-producing abilities for biofuel production.


Stub icon
   This article is a medical stub. You can help WikiMD by expanding it!


Navigation: Wellness - Encyclopedia - Health topics - Disease Index‏‎ - Drugs - World Directory - Gray's Anatomy - Keto diet - Recipes

Ad. Transform your health with W8MD Weight Loss, Sleep & MedSpa

W8MD's happy loser(weight)

Tired of being overweight?

Special offer:

Budget GLP-1 weight loss medications

  • Semaglutide starting from $29.99/week and up with insurance for visit of $59.99 and up per week self pay.
  • Tirzepatide starting from $45.00/week and up (dose dependent) or $69.99/week and up self pay

✔ Same-week appointments, evenings & weekends

Learn more:

Advertise on WikiMD


WikiMD Medical Encyclopedia

Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.